Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to confirm that is has successfully completed the Innovate UK grant project announced in March 2018. The project was formally signed off by Innovate UK following a final project meeting in April 2019. The Company can confirm that, in line with expectations,...
Read More